- Home
- LVRO vs TRVI Comparison
LVRO vs TRVI Comparison
Compare LVRO & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- TRVI
- Stock Information
- Founded
- LVRO 2017
- TRVI 2011
- Country
- LVRO Brazil
- TRVI United States
- Employees
- LVRO N/A
- TRVI N/A
- Industry
- LVRO Blank Checks
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- LVRO Finance
- TRVI Health Care
- Exchange
- LVRO Nasdaq
- TRVI Nasdaq
- Market Cap
- LVRO 387.1M
- TRVI 363.7M
- IPO Year
- LVRO N/A
- TRVI 2019
- Fundamental
- Price
- LVRO $4.90
- TRVI $4.60
- Analyst Decision
- LVRO Strong Buy
- TRVI Strong Buy
- Analyst Count
- LVRO 3
- TRVI 8
- Target Price
- LVRO $5.83
- TRVI $9.31
- AVG Volume (30 Days)
- LVRO 4.2K
- TRVI 739.7K
- Earning Date
- LVRO 02-03-2025
- TRVI 03-19-2025
- Dividend Yield
- LVRO N/A
- TRVI N/A
- EPS Growth
- LVRO N/A
- TRVI N/A
- EPS
- LVRO N/A
- TRVI N/A
- Revenue
- LVRO $1,667,345,189.00
- TRVI N/A
- Revenue This Year
- LVRO N/A
- TRVI N/A
- Revenue Next Year
- LVRO $13.35
- TRVI N/A
- P/E Ratio
- LVRO N/A
- TRVI N/A
- Revenue Growth
- LVRO N/A
- TRVI N/A
- 52 Week Low
- LVRO $3.06
- TRVI $2.30
- 52 Week High
- LVRO $7.58
- TRVI $5.05
- Technical
- Relative Strength Index (RSI)
- LVRO 56.49
- TRVI 62.80
- Support Level
- LVRO $4.28
- TRVI $3.93
- Resistance Level
- LVRO $5.40
- TRVI $4.14
- Average True Range (ATR)
- LVRO 0.48
- TRVI 0.29
- MACD
- LVRO 0.05
- TRVI 0.06
- Stochastic Oscillator
- LVRO 62.94
- TRVI 64.82
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.